Menu
Recruiting NCT05638841

Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation

— Observational Atrial Fibrillation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: After radiofrequency ablation of atrial fibrillation.
Who it may be relevant to
Registry conditions: Atrial Fibrillation. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.

Interventions

  • Other After radiofrequency ablation of atrial fibrillation
    This study imposed an intervention. Clinical data were obtained by telephone or outpatient follow-up.

Primary outcome measures

  • Compound cardiovascular event [Time frame: 24 months]

Eligibility criteria

Inclusion criteria

  • 1\) Age > 18
  • 2\) ECG or holter electrocardiogram confirmed atrial fibrillation

Exclusion criteria

  • 1\) Hematological diseases, autoimmune diseases and malignant tumors
  • 2\) Immobility caused by hemiplegia or severe trauma
  • 3\) The expected survival time is less than 2 years
  • 4\) Poor compliance and high risk of expected loss of follow-up
  • 5\) Disorders of consciousness or Alzheimer's disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

China · 1 center
  • Peking-University-Third-Hospital — Beijing

Identifiers

NCT: NCT05638841 · 2022-653-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗